English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA study of persons with gout and type 2 diabetes found that the use of sodium–glucose cotransporter-2 inhibitors (SGLT2is) may reduce recurrent flares and gout-primary emergency department (ED) visits and hospitalizations compared to treatment with dipeptidyl peptidase 4 inhibitors (DPP-4is). SGLT2is may also provide greater cardiovascular benefits in this population. The findings are published in Annals of Internal Medicine.
Tag: Gout management
Gout Treatment Success Doubled by Combining Two Drugs, Study Finds
If left untreated, gout can cause severe disability. But unlike rheumatoid arthritis, there are only a handful of ways to treat it. Researchers say a combination of two existing drugs disrupts antibody production and doubles treatment efficacy.